Lodosyn | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Lodosyn
Others

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

jdmfs-not-supported-m-2025-08-11

Lodosyn

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 22 USDMF, 17 CEP/COS, 8 JDMF, 3 EU WC, 8 KDMF, 15 NDC API, 17 Listed Suppliers, $ API Reference Price

50 API Suppliers
22 USDMF
17 CEP/COS
8 JDMF
3 EU WC
8 KDMF
15 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

FINISHED DOSAGE FORMULATIONS

360 FDF Dossiers, 127 FDA Orange Book, 167 Europe, 25 Canada, 12 South Africa, 29 Listed Dossiers

360 FDF Dossiers
127 FDA Orange Book
167 Europe
25 Canada
12 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET;ORAL - 25MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 8 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 37 Direct Compression, 34 Granulation, 34 Solubilizers, 34 Thickeners and Stabilizers, 33 Controlled & Modified Release, 26 Taste Masking, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 22 Film Formers & Plasticizers, 21 Parenteral, 15 Topical, 15 Co-Processed Excipients, 10 Rheology Modifiers, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

78 Fillers, Diluents & Binders
59 Coating Systems & Additives
46 Disintegrants & Superdisintegrants
37 Direct Compression
34 Granulation
34 Solubilizers
34 Thickeners and Stabilizers
33 Controlled & Modified Release
26 Taste Masking
23 Chewable & Orodispersible Aids
22 Lubricants & Glidants
22 Film Formers & Plasticizers
21 Parenteral
15 Topical
15 Co-Processed Excipients
10 Rheology Modifiers
8 API Stability Enhancers
8 Emulsifying Agents
5 Coloring Agents
5 Empty Capsules
4 Surfactant & Foaming Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 74 News #PharmaBuzz

2 Data Compilation #PharmaFlow
74 News #PharmaBuzz

GLOBAL SALES INFORMATION

44 US Medicaid Prescriptions, 150 Regulatory FDF Prices, 12 Annual Reports

44 US Medicaid Prescriptions
150 Regulatory FDF Prices
12 Annual Reports

MARKET PLACE

13 APIs, 9 FDF Dossiers

13 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

237 US Patents, 4 US Exclusivities

237 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 7 Others

3 EDQM
1 USP
1 JP
7 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 359 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

7 All

01 4 Aozeal Certified Standards

02 1Creative Peptides

03 2USP

filter CAS Number Reset all filters

7 All

01 11246817-47-9

02 11246819-09-9

03 118181-08-3

04 238821-49-7

05 185933-19-3

06 1Blank

filter Details Reset all filters

7 All

01 1Carbidopa?(Lodosyn) is a?drug?given to people with?Parkinson's disease?in order to inhibit?peripheral?metabolism?oflevodopa. This property is significant in that it allows a greater proportion of peripheral?levodopa?to cross the blood?brain barrier for central nervous system effect. More information please visit the website: http://www.creative-peptides.com/product/carbidopa-item-10-101-135-25.html

02 4In stock

03 2Material Origin- Chemical Synthesis; USMCA- No; KORUS- No

filter Country Reset all filters

7 All

01 2Gabon

02 5U.S.A

Product Main Page

01

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CarbidopA EP Impurity B

CAS Number : 18181-08-3

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : C0068.18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Rac-CarbidopA EP Impurity C

CAS Number : 85933-19-3

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : C0068.02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Rac-CarbidopA EP Impurity I

CAS Number : 1246819-09-9

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : C0068.11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Aozeal Certified Standards

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Rac-CarbidopA EP Impurity J

CAS Number : 1246817-47-9

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : C0068.06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Creative Peptides

ACS Fall 2025

Not Confirmed

Creative Peptides

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CAS Number : 38821-49-7

Quantity Per Vial :

Sale Unit :

Price :

Details : Carbidopa?(Lodosyn) is a?drug?given to people...

Monograph :

Storage :

Code/Batch No : 10-101-135

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

XYZ Pharma

ACS Fall 2025

Not Confirmed

XYZ Pharma

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Carbidopa (400 mg)

CAS Number : 38821-49-7

Quantity Per Vial : 400

Sale Unit : mg

Price : $245.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1095506 / R097J0

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

07

XYZ Pharma

ACS Fall 2025

Not Confirmed

XYZ Pharma

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Carbidopa Related Compound A (25 mg) (3-O-Met...

CAS Number :

Quantity Per Vial : 25

Sale Unit : mg

Price : $835.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1095517 / R065X0

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!